Cas no 1185112-19-9 (Hydroxy Tolbutamide-d9)

Hydroxy Tolbutamide-d9 is a deuterated analog of hydroxy tolbutamide, a metabolite of the antidiabetic drug tolbutamide. This stable isotope-labeled compound is primarily used as an internal standard in quantitative mass spectrometry analyses, ensuring high accuracy and precision in pharmacokinetic and metabolic studies. The incorporation of nine deuterium atoms enhances its molecular distinction from the non-labeled analyte, minimizing interference during detection. Its high chemical purity and isotopic enrichment make it a reliable reference material for research involving drug metabolism, bioavailability, and bioequivalence. Hydroxy Tolbutamide-d9 is particularly valuable in LC-MS/MS applications, where consistent performance and reproducibility are critical.
Hydroxy Tolbutamide-d9 structure
Hydroxy Tolbutamide-d9 structure
Product Name:Hydroxy Tolbutamide-d9
CAS No:1185112-19-9
MF:C12H9D9N2O4S
MW:295.40300
CID:895447
PubChem ID:45039534
Update Time:2025-06-11

Hydroxy Tolbutamide-d9 Chemical and Physical Properties

Names and Identifiers

    • Hydroxy Tolbutamide-d9
    • 1-[4-(hydroxymethyl)phenyl]sulfonyl-3-(1,1,2,2,3,3,4,4,4-nonadeuteriobutyl)urea
    • Hydroxymethylcarbutamide-d9
    • 4-Hydroxytolbutamide-d9
    • N-[(~2~H_9_)Butylcarbamoyl]-4-(hydroxymethyl)benzene-1-sulfonamide
    • HY-100641S
    • Hydroxytolbutamide-d9 (butyl-d9)
    • F91041
    • 1185112-19-9
    • Hydroxy Tolbutamide D9
    • MS-24231
    • CS-0202027
    • J-003804
    • DTXSID80662029
    • 3-[(1,1,2,2,3,3,4,4,4-?H?)butyl]-1-[4-(hydroxymethyl)benzenesulfonyl]urea
    • Inchi： InChI=1S/C12H18N2O4S/c1-2-3-8-13-12(16)14-19(17,18)11-6-4-10(9-15)5-7-11/h4-7,15H,2-3,8-9H2,1H3,(H2,13,14,16)/i1D3,2D2,3D2,8D2
    • InChI Key： SJRHYONYKZIRPM-UHFFFAOYSA-N
    • SMILES： CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)CO

Computed Properties

  • Exact Mass: 295.15500
  • Monoisotopic Mass: 295.15521895g/mol
  • Isotope Atom Count: 9
  • Hydrogen Bond Donor Count: 3
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 19
  • Rotatable Bond Count: 6
  • Complexity: 370
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.1
  • Topological Polar Surface Area: 104?2

Experimental Properties

  • Density: 1.3±0.1 g/cm3
  • Melting Point: 100-103°C
  • PSA: 107.37000
  • LogP: 2.64300

Hydroxy Tolbutamide-d9 Security Information

Hydroxy Tolbutamide-d9 Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
H969852-1mg
Hydroxy Tolbutamide-d9
 1185112-19-9
1mg
 $ 201.00 2023-09-07
TRC
H969852-10mg
Hydroxy Tolbutamide-d9
 1185112-19-9
10mg
 $ 1533.00 2023-09-07
ChemScence
CS-0202027-10mg
4-Hydroxytolbutamide-d9
 1185112-19-9
10mg
 $0.0 2022-04-28
ChemScence
CS-0202027-1mg
4-Hydroxytolbutamide-d9
 1185112-19-9
1mg
 $0.0 2022-04-28
MedChemExpress
HY-100641S-1mg
4-Hydroxytolbutamide-d
 1185112-19-9 99.29%
1mg
 ￥4100 2025-04-16
Key Organics Ltd
MS-24231-1mg
4-Hydroxytolbutamide-d9
 1185112-19-9 >97%
1mg
 ￡801.25 2025-02-09
A2B Chem LLC
AE10610-1mg
HYDROXY TOLBUTAMIDE-D9
 1185112-19-9 99%
1mg
 $525.00 2024-04-20
MedChemExpress
HY-100641S-500μg
4-Hydroxytolbutamide-d
 1185112-19-9 99.29%
500μg
 ￥2500 2025-04-16

Hydroxy Tolbutamide-d9 Related Literature

Related Categories

Additional information on Hydroxy Tolbutamide-d9

Comprehensive Guide to Hydroxy Tolbutamide-d9 (CAS No. 1185112-19-9): Applications, Mechanisms, and Research Insights

Hydroxy Tolbutamide-d9 (CAS No. 1185112-19-9) is a deuterated analog of the well-known sulfonylurea drug Tolbutamide, widely used in diabetes research. This stable isotope-labeled compound has gained significant attention in pharmaceutical and metabolic studies due to its unique properties, such as enhanced metabolic stability and traceability in analytical assays. Researchers leverage Hydroxy Tolbutamide-d9 as an internal standard in LC-MS (Liquid Chromatography-Mass Spectrometry) to improve the accuracy of pharmacokinetic and pharmacodynamic analyses.

The growing demand for deuterated compounds in drug development aligns with current trends in precision medicine and personalized therapeutics. Hydroxy Tolbutamide-d9 exemplifies this shift, as its deuterium substitution reduces the rate of metabolic degradation, a feature highly sought after in drug metabolism studies. This compound is particularly valuable for investigating CYP2C9 enzyme activity, a critical factor in interindividual variability in drug response. With the rise of AI-driven drug discovery, tools like Hydroxy Tolbutamide-d9 provide essential data to train algorithms predicting drug interactions and metabolic pathways.

From a technical perspective, Hydroxy Tolbutamide-d9 is synthesized with nine deuterium atoms replacing hydrogen at specific positions, ensuring minimal isotopic effect while maximizing analytical utility. Its molecular weight (311.42 g/mol) and high purity (typically >98%) make it ideal for quantitative bioanalysis. Recent publications highlight its role in diabetes research, especially in studies exploring the relationship between sulfonylurea drugs and pancreatic beta-cell function. As the scientific community focuses on sustainable chemistry, the use of deuterated standards like Hydroxy Tolbutamide-d9 reduces the need for repeated experiments, minimizing resource consumption.

In the context of global health challenges, such as the increasing prevalence of type 2 diabetes, Hydroxy Tolbutamide-d9 contributes to advancing diagnostic and therapeutic strategies. Its application extends to clinical trial monitoring, where precise measurement of drug metabolites is crucial for assessing efficacy and safety. Furthermore, the compound’s compatibility with high-throughput screening platforms supports the pharmaceutical industry’s push toward faster, data-rich drug development cycles. As regulatory agencies emphasize reproducible research, standardized tools like Hydroxy Tolbutamide-d9 become indispensable for ensuring data integrity across laboratories.

The future of Hydroxy Tolbutamide-d9 research lies in its integration with emerging technologies such as organ-on-a-chip systems and machine learning models for metabolic prediction. Its role in elucidating drug-drug interactions—especially relevant for polypharmacy in aging populations—further underscores its relevance. For laboratories seeking reliable reference materials, Hydroxy Tolbutamide-d9 (CAS No. 1185112-19-9) represents a robust choice, bridging the gap between traditional pharmacology and cutting-edge biomarker discovery.

1185112-19-9 (Hydroxy Tolbutamide-d9) Related Products

Recommended suppliers
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
HANGZHOU BAIS CHEMICAL TECHNOLOGY CO., LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
HANGZHOU BAIS CHEMICAL TECHNOLOGY CO., LTD.
SunaTech Inc.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
SunaTech Inc.